TARGET SKIN LESION

TARGET SKIN LESION was reported 114 times

These drug classes are most commonly taken by patients reporting TARGET SKIN LESION:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 15
1 Atypical Antipsychotic [EPC] 13
2 Corticosteroid [EPC] 13
3 Mood Stabilizer [EPC] 11
4 Thalidomide Analog [EPC] 9
5 Vitamin C [EPC] 9
6 Anti-epileptic Agent [EPC] 8
7 Proteasome Inhibitor [EPC] 8
8 Vitamin B12 [EPC] 8
9 Vitamin D [EPC] 8
10 Proton Pump Inhibitor [EPC] 7
11 Serotonin-3 Receptor Antagonist [EPC] 6
12 Factor Xa Inhibitor [EPC] 5
13 Folate Analog Metabolic Inhibitor [EPC] 5
14 Leukocyte Growth Factor [EPC] 5
15 Platinum-based Drug [EPC] 5
16 Aldosterone Antagonist [EPC] 4
17 Glycopeptide Antibacterial [EPC] 4
18 Tumor Necrosis Factor Blocker [EPC] 4
19 Calcium Channel Blocker [EPC] 3
20 Dihydropyridine Calcium Channel Blocker [EPC] 3
21 Loop Diuretic [EPC] 3
22 Nitroimidazole Antimicrobial [EPC] 3
23 Platelet Aggregation Inhibitor [EPC] 3
24 Aminosalicylate [EPC] 2
25 Benzodiazepine [EPC] 2
26 Interleukin-4 Receptor alpha Antagonist [EPC] 2
27 Kinase Inhibitor [EPC] 2
28 Microtubule Inhibitor [EPC] 2
29 Osmotic Laxative [EPC] 2
30 Xanthine Oxidase Inhibitor [EPC] 2
31 Acetylcholine Release Inhibitor [EPC] 1
32 Alkylating Drug [EPC] 1
33 Angiotensin 2 Receptor Blocker [EPC] 1
34 Anticholinergic [EPC] 1
35 Antirheumatic Agent [EPC] 1
36 CD52-directed Cytolytic Antibody [EPC] 1
37 Calcineurin Inhibitor Immunosuppressant [EPC] 1
38 Histamine-2 Receptor Antagonist [EPC] 1
39 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
40 Insulin [EPC] 1
41 Interleukin-23 Antagonist [EPC] 1
42 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
43 Neuromuscular Blocker [EPC] 1
44 Oxytocic [EPC] 1
45 Polyene Antifungal [EPC] 1
46 Potassium Salt [EPC] 1
47 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
48 Provitamin D2 Compound [EPC] 1
49 RANK Ligand Inhibitor [EPC] 1
50 Vesicular Monoamine Transporter 2 Inhibitor [EPC] 1